Longeveron to raise $6.2 million through warrant exercises By Investing.com

Published on 17 Apr 2024 on Investing.com

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company, announced today that it has...

Read the rest of the article

Start tracking your investments with Statfolio

On April 16, Zerella sold a total of 32,500 shares of Class A Common Stock at a weighted average...

Investing.com 17 Apr 2024

This action, captioned Taylor Jr. v. The Chemours Company, et al., Case No. 1:24-cv-00361-RGA, wa...

FOX 4 Kansas City 17 Apr 2024

Matthew Shair has sold a significant portion of his holdings in the company, according to the lat...

Investing.com 17 Apr 2024

Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company, announced today that it h...

Investing.com 17 Apr 2024

Apr. 12, 2024), asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of...

Investing.com 12 Apr 2024

In a recent transaction, David Jolley, the Chief Financial Officer of Domo, Inc. (NASDAQ:DOMO), s...

Investing.com 12 Apr 2024

Direct Selling Acquisition Corp. (NYSE: DSAQ) (the "Company") today announced its intention to...

WROC Rochester 12 Apr 2024

(NYNYSE: S E:S), sold shares of the company's Class A Common Stock. On April 11, 2024, Weingarten...

Investing.com 12 Apr 2024

(NYNYSE:SE:S), sold shares of the company's Class A Common Stock, totaling approximately $2.12...

Investing.com 11 Apr 2024

In a recent filing, the NYSE notified the U.S. Securities and Exchange Commission (SEC) of its pl...

InvestorPlace 11 Apr 2024